Aviva plc
Aviva plc (AVVIY) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Aviva plc (AVVIY), featuring income statements, balance sheets, and cash flow data.
Aviva plc (AVVIY) Income Statement & Financial Overview
View the income breakdown for Aviva plc AVVIY across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $19.07B | $10.84B | $26.86B | $14.46B |
| Cost of Revenue | $19.07B | -$10.94B | $6.76B | -$170.00M |
| Gross Profit | $0.00 | $21.79B | $20.10B | $14.63B |
| Gross Profit Ratio | $0.00 | $2.009 | $0.75 | $1.01 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $10.94B | $12.00M | $13.00M |
| Operating Expenses | $0.00 | $10.94B | $7.80B | $1.65B |
| Total Costs & Expenses | $23.00M | -$20.92B | -$25.45B | -$13.78B |
| Interest Income | $0.00 | $0.00 | $136.00M | $240.00M |
| Interest Expense | $228.00M | $263.00M | $0.00 | $253.00M |
| Depreciation & Amortization | $0.00 | -$10.62B | -$2.16B | -$359.00M |
| EBITDA | $434.00M | $220.00M | $12.15B | $100.00M |
| EBITDA Ratio | $0.02 | $0.02 | -$0.04 | $0.007 |
| Operating Income | $451.00M | $10.84B | $2.16B | $359.00M |
| Operating Income Ratio | $0.02 | $1.00 | $0.08 | $0.02 |
| Other Income/Expenses (Net) | -$245.00M | -$9.87B | -$10.96B | -$9.24B |
| Income Before Tax | $206.00M | $978.00M | $1.23B | $533.00M |
| Income Before Tax Ratio | $0.01 | $0.09 | $0.05 | $0.04 |
| Income Tax Expense | $238.00M | $324.00M | $465.00M | $119.00M |
| Net Income | $24.00M | $626.00M | $702.00M | $349.00M |
| Net Income Ratio | $0.001 | $0.06 | $0.03 | $0.02 |
| EPS | $0.006 | $0.23 | $0.26 | $0.12 |
| Diluted EPS | $0.005 | $0.23 | $0.26 | $0.12 |
| Weighted Avg Shares Outstanding | $2.66B | $2.71B | $2.72B | $2.77B |
| Weighted Avg Shares Outstanding (Diluted) | $3.17B | $2.71B | $2.72B | $2.80B |
Over the last four quarters, Aviva plc achieved steady financial progress, growing revenue from $14.46B in Q2 2023 to $19.07B in Q4 2024. Gross profit stayed firm with margins at N/A in Q4 2024 versus 101% in Q2 2023. Operating income totaled $451.00M in Q4 2024, maintaining a 2% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $434.00M. Net income dropped to $24.00M, with EPS at $0.006. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan